Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI
Clinical trial NCT01874522 · COMPLETED
Trial details
- NCT number
- NCT01874522
- Sponsor
- Taiho Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-08-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.